![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | TMEM254 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TMEM254 mRNA | CTD | PMID:24763279 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of TMEM254 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TMEM254 mRNA | CTD | PMID:21215274 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Tmem254 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of TMEM254 mRNA | CTD | PMID:16214954 | 2-hydroxypropanoic acid | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of TMEM254 mRNA | CTD | PMID:30851411 | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | TMEM254 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Tmem254 (Mus musculus) | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with LIF protein] affects the expression of TMEM254 mRNA more ... | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | affects expression | ISO | Tmem254 (Mus musculus) | 6480464 | bis(4-hydroxyphenyl)sulfone affects the expression of TMEM254 mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of TMEM254 mRNA | CTD | PMID:28973697 | aflatoxin B1 | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of TMEM254 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | multiple interactions | ISO | Tmem254 (Mus musculus) | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA more ... | CTD | PMID:30951980 | Aroclor 1254 | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of TMEM254 mRNA | CTD | PMID:25270620 | benzo[a]pyrene | increases methylation | ISO | TMEM254 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of TMEM254 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | TMEM254 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of TMEM254 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Tmem254 (Mus musculus) | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of TMEM254 mRNA] | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | increases expression | ISO | Tmem254 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of TMEM254 mRNA | CTD | PMID:19850644 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of TMEM254 mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | multiple interactions | ISO | Tmem254 (Mus musculus) | 6480464 | [bisphenol A co-treated with LIF protein] results in increased expression of TMEM254 mRNA more ... | CTD | PMID:30951980 | bisphenol A | increases expression | ISO | Tmem254 (Mus musculus) | 6480464 | bisphenol A results in increased expression of TMEM254 mRNA | CTD | PMID:30951980 and PMID:33221593 | bisphenol A | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of TMEM254 mRNA | CTD | PMID:30951980 and PMID:35598803 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TMEM254 mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol F | multiple interactions | ISO | TMEM254 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | ISO | Tmem254 (Mus musculus) | 6480464 | [bisphenol F co-treated with LIF protein] results in decreased expression of TMEM254 mRNA more ... | CTD | PMID:30951980 | bisphenol F | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of TMEM254 mRNA | CTD | PMID:30951980 | bisphenol F | increases expression | ISO | Tmem254 (Mus musculus) | 6480464 | bisphenol F results in increased expression of TMEM254 mRNA | CTD | PMID:30951980 | bortezomib | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of TMEM254 mRNA | CTD | PMID:20977926 | butanal | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of TMEM254 mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of TMEM254 promoter | CTD | PMID:22457795 | copper(II) sulfate | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of TMEM254 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of TMEM254 mRNA | CTD | PMID:20106945 and PMID:25562108 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of TMEM254 mRNA | CTD | PMID:23914054 | dexamethasone | multiple interactions | ISO | TMEM254 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA | CTD | PMID:28628672 | dorsomorphin | multiple interactions | ISO | TMEM254 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA | CTD | PMID:27188386 | endosulfan | affects expression | EXP | | 6480464 | Endosulfan affects the expression of TMEM254 mRNA | CTD | PMID:29391264 | fluoranthene | multiple interactions | ISO | Tmem254 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM254 mRNA | CTD | PMID:28329830 | fluoranthene | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | fluoranthene results in decreased expression of TMEM254 mRNA | CTD | PMID:28329830 | Heptachlor epoxide | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | Heptachlor Epoxide results in decreased expression of TMEM254 mRNA | CTD | PMID:25270620 | indometacin | multiple interactions | ISO | TMEM254 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA | CTD | PMID:28628672 | isotretinoin | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of TMEM254 mRNA | CTD | PMID:20436886 | lead diacetate | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | lead acetate results in decreased expression of TMEM254 mRNA | CTD | PMID:25270620 | methylmercury chloride | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of TMEM254 mRNA | CTD | PMID:28001369 | nickel atom | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Nickel results in decreased expression of TMEM254 mRNA | CTD | PMID:23195993 and PMID:24768652 | paracetamol | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of TMEM254 mRNA | CTD | PMID:29246445 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of TMEM254 mRNA | CTD | PMID:33387578 | paracetamol | affects expression | ISO | Tmem254 (Mus musculus) | 6480464 | Acetaminophen affects the expression of TMEM254 mRNA | CTD | PMID:17562736 | paracetamol | multiple interactions | ISO | Tmem254 (Mus musculus) | 6480464 | PANX1 gene mutant form promotes the reaction [Acetaminophen results in decreased expression of TMEM254 mRNA] | CTD | PMID:29246445 | pentanal | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | pentanal results in decreased expression of TMEM254 mRNA | CTD | PMID:26079696 | pirinixic acid | increases expression | ISO | Tmem254 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of TMEM254 mRNA | CTD | PMID:18301758 and PMID:23811191 | rac-lactic acid | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of TMEM254 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | TMEM254 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA | CTD | PMID:27188386 | sunitinib | increases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of TMEM254 mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of TMEM254 mRNA | CTD | PMID:31758290 | Tributyltin oxide | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of TMEM254 mRNA | CTD | PMID:25270620 | triptonide | increases expression | ISO | Tmem254 (Mus musculus) | 6480464 | triptonide results in increased expression of TMEM254 mRNA | CTD | PMID:33045310 | tunicamycin | increases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of TMEM254 mRNA | CTD | PMID:29453283 | urethane | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Urethane results in decreased expression of TMEM254 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TMEM254 mRNA | CTD | PMID:19101580 | valproic acid | affects expression | ISO | Tmem254 (Mus musculus) | 6480464 | Valproic Acid affects the expression of TMEM254 mRNA | CTD | PMID:17292431 and PMID:17963808 | valproic acid | decreases expression | ISO | Tmem254 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of TMEM254 mRNA | CTD | PMID:21427059 | valproic acid | decreases expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TMEM254 mRNA | CTD | PMID:24935251 more ... | valproic acid | multiple interactions | ISO | TMEM254 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA | CTD | PMID:27188386 | valproic acid | affects expression | ISO | TMEM254 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TMEM254 mRNA | CTD | PMID:25979313 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of TMEM254 mRNA | CTD | PMID:23034163 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of TMEM254 mRNA | CTD | PMID:22570695 | |